TABLE OF CONTENTS
1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 54
1.3 OVERVIEW OF THE GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET 54
1.4 LIMITATIONS 56
1.5 MARKETS COVERED 56
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 DBMR TRIPOD DATA VALIDATION MODEL 62
2.6 MULTIVARIATE MODELLING 65
2.7 PRODUCT TYPE LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 DBMR MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 68
2.11 VENDOR SHARE ANALYSIS 69
2.12 SECONDARY SOURCES 70
2.13 ASSUMPTIONS 70
3 EXECUTIVE SUMMARY 71
4 PREMIUM INSIGHTS 73
4.1 PORTER’S FIVE FORCES 76
4.2 PESTEL ANALYSIS 77
4.3 MICRO AND MACRO ECONOMIC FACTORS 78
4.4 PENETRATION AND GROWTH PROSPECT MAPPING 78
4.5 KEY PRICING STRATEGIES 79
5 REGULATORY COMPLIANCE 80
5.1 REGULATORY AUTHORITIES 80
5.2 REGULATORY CLASSIFICATIONS 80
5.3 REGULATORY SUBMISSIONS 80
5.4 INTERNATIONAL HARMONIZATION 81
5.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO 82
5.6 REGULATORY CHALLENGES AND STRATEGY 82
5.6.1 REGULATORY SCENARIO IN THE U.S. 82
5.6.2 REGULATORY SCENARIO IN EUROPE 83
5.6.3 REGULATORY SCENARIO IN CHINA 83
6 MARKET OVERVIEW 84
6.1 DRIVERS 86
6.1.1 RISE IN AVAILABILITY OF DIGITAL PCR DIAGNOSTICS 86
6.1.2 INCREASING APPLICATION OF DIGITAL PCR 86
6.1.3 INCREASING DEMAND FOR PERSONALIZED MEDICINE 87
6.2 RESTRAINTS 87
6.2.1 LIMITATIONS IN ANALYZING NOVEL COMPLEX DEVICES 87
6.2.2 HIGH COST OF DIGITAL PCR DEVICES 88
6.3 OPPORTUNITIES 88
6.3.1 RISING FREQUENCY OF INFECTIOUS DISEASES 88
6.3.2 RISING PRODUCT INNOVATIONS THROUGH R&D ACTIVITIES 88
6.4 CHALLENGES 89
6.4.1 STRINGENT REGULATIONS AND LEGAL CHALLENGES FOR DIGITAL PCR 89
6.4.2 LACK OF SKILLED PROFESSIONALS PERFORMING DIGITAL PCR 89
7 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY PRODUCT TYPE 91
7.1 OVERVIEW 92
7.2 DIGITAL PCR INSTRUMENTS 95
7.2.1 BY MODALITY 95
7.2.1.1 STANDLONE 95
7.2.1.2 PORTABLE 95
7.2.2 BY METHOD 95
7.2.2.1 PLATE-BASED DPCR 96
7.2.2.2 CHIP BASED DPCR 96
7.2.2.3 MICROFLUIDIC CHAMBER BASED DPCR 96
7.2.2.4 OTHERS 96
7.3 CONSUMABLES AND REAGENTS 96
7.3.1 REAGENTS 96
7.3.1.1 DNA OR PCR TEMPLATES 97
7.3.1.2 DNA POLYMERASE ENZYME 97
7.3.1.3 PRIMERS 97
7.3.1.4 DEXOYNUCLEOTIDE TRIPHOSPHATES (DNTPS) 97
7.3.1.5 PCR BUFFERS 97
7.3.1.6 PCR KIT 97
7.3.2 CONSUMABLES 98
7.3.2.1 PLATES 98
7.3.2.2 TUBES & CAPS 98
7.3.2.3 PLASTIC ACCESSORIES 98
7.3.2.4 PLATE SEALS 98
7.3.2.5 CARTRIDGES 99
7.3.2.6 OTHERS 99
7.4 SOFTWARE AND SERVICES 99
8 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY TECHNOLOGY 100
8.1 OVERVIEW 101
8.2 DROPLET DIGITAL PCR 104
8.2.1 CLINICAL 104
8.2.2 LIFE SCIENCE & RESEARCH 104
8.2.3 OTHERS 104
8.3 BEAMING DIGITAL PCR 105
8.3.1 CLINICAL 105
8.3.2 LIFE SCIENCE & RESEARCH 105
8.3.3 OTHERS 105
9 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY APPLICATION 106
9.1 OVERVIEW 107
9.2 CLINICAL 110
9.2.1 ONCOLOGY TESTING 110
9.2.2 INFECTIOUS DISEASE TESTING 110
9.2.2.1 HIV 111
9.2.2.2 HCV 111
9.2.2.3 HEPATITIS B VIRUS 111
9.2.2.4 HUMAN PAPILLOMAVIRUS 111
9.2.2.5 OTHERS 111
9.2.3 BLOOD SCREENING 111
9.2.4 TRANSPLANT DIAGNOSTICS 111
9.3 LIFE SCIENCE & RESEARCH 112
9.3.1 MICROBIOLOGY 112
9.3.2 MOLECULAR AND CELL BIOLOGY 112
9.3.3 OTHERS 112
9.4 OTHERS 112
10 GLOBAL DIGITAL POLYMERASE CHAIN (PCR) REACTION MARKET, BY END USER 113
10.1 OVERVIEW 114
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 117
10.3 HOSPITALS AND CLINICS 117
10.3.1 PRIVATE 117
10.3.1.1 TIER 1 117
10.3.1.2 TIER 2 118
10.3.1.3 TIER 3 118
10.3.2 PUBLIC 118
10.3.2.1 TIER 1 118
10.3.2.2 TIER 2 118
10.3.2.3 TIER 3 118
10.4 DIAGNOSTIC LABORATORIES 119
10.5 ACADEMIC AND RESEARCH ORGANIZATIONS 119
10.6 REFERENCE LABORATORIES 119
10.7 OTHERS 119
11.1 OVERVIEW 121
11.2 DIRECT TENDER 124
11.3 RETAIL SALES 124
11.4 OTHERS 124
12 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY REGION 125
12.1 OVERVIEW 126
12.2 NORTH AMERICA 131
12.3 EUROPE 152
12.4 ASIA-PACIFIC 233
12.5 SOUTH AMERICA 304
12.6 MIDDLE EAST AND AFRICA 329
13 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET, COMPANY LANDSCAPE 372
13.1 COMPANY SHARE ANALYSIS: GLOBAL 372
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 373
13.3 COMPANY SHARE ANALYSIS: EUROPE 374
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 375
14 SWOT ANALYSIS 376
15 COMPANY PROFILE 377
15.1 F. HOFFMANN- LA ROCHE LTD 377
15.1.1 COMPANY SNAPSHOT 377
15.1.2 REVENUE ANALYSIS 377
15.1.3 COMPANY SHARE ANALYSIS 378
15.1.4 PRODUCT PORTFOLIO 378
15.1.5 RECENT DEVELOPMENT 378
15.2 BIO-RAD LABORATORIES, INC 379
15.2.1 COMPANY SNAPSHOT 379
15.2.2 REVENUE ANALYSIS 379
15.2.3 COMPANY SHARE ANALYSIS 380
15.2.4 PRODUCT PORTFOLIO 380
15.2.5 RECENT DEVELOPMENTS 380
15.3 MERCK KGAA 382
15.3.1 COMPANY SNAPSHOT 382
15.3.2 REVENUE ANALYSIS 382
15.3.3 COMPANY SHARE ANALYSIS 383
15.3.4 PRODUCT PORTFOLIO 383
15.3.5 RECENT DEVELOPMENT 383
15.4 THERMO FISHER SCIENTIFIC 384
15.4.1 COMPANY SNAPSHOT 384
15.4.2 REVENUE ANALYSIS 384
15.4.3 COMPANY SHARE ANALYSIS 385
15.4.4 PRODUCT PORTFOLIO 385
15.4.5 RECENT DEVELOPMENTS 385
15.5 QIAGEN 387
15.5.1 COMPANY SNAPSHOT 387
15.5.2 REVENUE ANALYSIS 387
15.5.3 COMPANY SHARE ANALYSIS 388
15.5.4 PRODUCT PORTFOLIO 388
15.5.5 RECENT DEVELOPMENT 388
15.6 ACCUMAX 390
15.6.1 COMPANY SNAPSHOT 390
15.6.2 PRODUCT PORTFOLIO 390
15.6.3 RECENT DEVELOPMENT 390
15.7 EPPENDORF SE 391
15.7.1 COMPANY SNAPSHOT 391
15.7.2 PRODUCT PORTFOLIO 391
15.7.3 RECENT DEVELOPMENT 391
15.8 JN MEDSYS 392
15.8.1 COMPANY SNAPSHOT 392
15.8.2 PRODUCT PORTFOLIO 392
15.8.3 RECENT DEVELOPMENT 393
15.9 PRECIGENOME LLC 394
15.9.1 COMPANY SNAPSHOT 394
15.9.2 PRODUCT PORTFOLIO 394
15.9.3 RECENT DEVELOPMENT 394
15.10 RAINSURE SCIENTIFIC 395
15.10.1 COMPANY SNAPSHOT 395
15.10.2 PRODUCT PORTFOLIO 395
15.10.3 RECENT DEVELOPMENT 395
15.11 STANDARD BIOTOOLS 396
15.11.1 COMPANY SNAPSHOT 396
15.11.2 REVENUE ANALYSIS 396
15.11.3 PRODUCT PORTFOLIO 397
15.11.4 RECENT DEVELOPMENT 397
15.12 STILLA 398
15.12.1 COMPANY SNAPSHOT 398
15.12.2 PRODUCT PORTFOLIO 398
15.12.3 RECENT DEVELOPMENT 398
15.13 SYSMEX CORPORATION 399
15.13.1 COMPANY SNAPSHOT 399
15.13.2 REVENUE ANALYSIS 399
15.13.3 PRODUCT PORTFOLIO 400
15.13.4 RECENT DEVELOPMENT 400
15.14 VSI ELECTRONICS PVT. LTD 401
15.14.1 COMPANY SNAPSHOT 401
15.14.2 PRODUCT PORTFOLIO 401
15.14.3 RECENT DEVELOPMENT 401
16 QUESTIONNAIRE 402
17 RELATED REPORTS 405
